GAM
Goldentree Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,179,215
| Closed | -$18.1M | – | 37 |
|
|
2025
Q1 | $18.1M | Sell |
1,179,215
-786,059
| -40% | -$12.1M | 1.29% | 24 |
|
|
2024
Q4 | $43.2M | Sell |
1,965,274
-339,719
| -15% | -$7.48M | 3.32% | 7 |
|
|
2024
Q3 | $41.5M | Sell |
2,304,993
-180,657
| -7% | -$3.25M | 3.31% | 9 |
|
|
2024
Q2 | $40.4M | Buy |
2,485,650
+427,000
| +21% | +$6.94M | 3.35% | 9 |
|
|
2024
Q1 | $29M | Sell |
2,058,650
-1,816,350
| -47% | -$25.6M | 2.31% | 17 |
|
|
2023
Q4 | $40.5M | Buy |
+3,875,000
| New | +$40.5M | 4.2% | 8 |
|
|
2023
Q1 | – | Sell |
-2,493,348
| Closed | -$22.7M | – | 37 |
|
|
2022
Q4 | $22.7M | Buy |
+2,493,348
| New | +$22.7M | 1.83% | 13 |
|
|
2022
Q3 | – | Sell |
-3,822,965
| Closed | -$28.7M | – | 33 |
|
|
2022
Q2 | $28.7M | Buy |
+3,822,965
| New | +$28.7M | 1.87% | 16 |
|
|
2019
Q2 | – | Sell |
-1,012,580
| Closed | -$15.9M | – | 25 |
|
|
2019
Q1 | $15.9M | Sell |
1,012,580
-839,055
| -45% | -$13.2M | 1.71% | 13 |
|
|
2018
Q4 | $28.6M | Buy |
+1,851,635
| New | +$28.6M | 4.5% | 7 |
|